295 related articles for article (PubMed ID: 26564072)
21. An update on the CNS manifestations of neurofibromatosis type 2.
Coy S; Rashid R; Stemmer-Rachamimov A; Santagata S
Acta Neuropathol; 2020 Apr; 139(4):643-665. PubMed ID: 31161239
[TBL] [Abstract][Full Text] [Related]
22. Combined retinal hamartomas leading to the diagnosis of neurofibromatosis type 2.
Grant EA; Trzupek KM; Reiss J; Crow K; Messiaen L; Weleber RG
Ophthalmic Genet; 2008 Sep; 29(3):133-8. PubMed ID: 18766994
[TBL] [Abstract][Full Text] [Related]
23. Bilateral vestibular schwannomas in older patients: NF2 or chance?
Evans DG; Freeman S; Gokhale C; Wallace A; Lloyd SK; Axon P; Ward CL; Rutherford S; King A; Huson SM; Ramsden RT;
J Med Genet; 2015 Jun; 52(6):422-4. PubMed ID: 25725045
[TBL] [Abstract][Full Text] [Related]
24. [Type 2 neurofibromatosis without acoustic neuroma].
Mautner VF; Lindenau M; Köppen J; Hazim W; Kluwe L
Zentralbl Neurochir; 1995; 56(2):83-7. PubMed ID: 7639047
[TBL] [Abstract][Full Text] [Related]
25. A case of neurofibromatosis type 2 (NF2) with classic imaging and skin findings.
Bhattacharjee S; Sinha P; Sarin A; Prasad BK
Med J Armed Forces India; 2018 Oct; 74(4):407-409. PubMed ID: 30449935
[TBL] [Abstract][Full Text] [Related]
26. Association of Genetic Predisposition With Solitary Schwannoma or Meningioma in Children and Young Adults.
Pathmanaban ON; Sadler KV; Kamaly-Asl ID; King AT; Rutherford SA; Hammerbeck-Ward C; McCabe MG; Kilday JP; Beetz C; Poplawski NK; Evans DG; Smith MJ
JAMA Neurol; 2017 Sep; 74(9):1123-1129. PubMed ID: 28759666
[TBL] [Abstract][Full Text] [Related]
27. Multiple meningiomas: differential involvement of the NF2 gene in children and adults.
Evans DG; Watson C; King A; Wallace AJ; Baser ME
J Med Genet; 2005 Jan; 42(1):45-8. PubMed ID: 15635074
[TBL] [Abstract][Full Text] [Related]
28. Clinical presentation, immunohistochemistry and electron microscopy indicate neurofibromatosis type 2-associated gliomas to be spinal ependymomas.
Hagel C; Stemmer-Rachamimov AO; Bornemann A; Schuhmann M; Nagel C; Huson S; Evans DG; Plotkin S; Matthies C; Kluwe L; Mautner VF
Neuropathology; 2012 Dec; 32(6):611-6. PubMed ID: 22394059
[TBL] [Abstract][Full Text] [Related]
29. Multiple schwannomas: schwannomatosis or neurofibromatosis type 2?
Seppälä MT; Sainio MA; Haltia MJ; Kinnunen JJ; Setälä KH; Jääskeläinen JE
J Neurosurg; 1998 Jul; 89(1):36-41. PubMed ID: 9647170
[TBL] [Abstract][Full Text] [Related]
30. Immunohistochemical detection of schwannomin and neurofibromin in vestibular schwannomas, ependymomas and meningiomas.
Huynh DP; Mautner V; Baser ME; Stavrou D; Pulst SM
J Neuropathol Exp Neurol; 1997 Apr; 56(4):382-90. PubMed ID: 9100669
[TBL] [Abstract][Full Text] [Related]
31. [Type 2 neurofibromatosis: intergenerational differences in genetic and clinical expression].
Drouet A; Le Moigne F; Salamé D; Quesnel L; Motolese C; des Portes V; Guilloton L; Pinson S
Arch Pediatr; 2014 Nov; 21(11):1233-40. PubMed ID: 25439059
[TBL] [Abstract][Full Text] [Related]
32. Infantile onset neurofibromatosis type 2 presenting with peripheral facial palsy, skin patches, retinal hamartoma and foot drop.
Tibussek D; Hübsch S; Berger K; Schaper J; Rosenbaum T; Mayatepek E
Klin Padiatr; 2009; 221(4):247-50. PubMed ID: 19629903
[TBL] [Abstract][Full Text] [Related]
33. Advances in Targeted Therapy for Neurofibromatosis Type 2 (NF2)-Associated Vestibular Schwannomas.
Cumpston EC; Rhodes SD; Yates CW
Curr Oncol Rep; 2023 May; 25(5):531-537. PubMed ID: 36933171
[TBL] [Abstract][Full Text] [Related]
34. [Neurofibromatosis type 2 (central neurofibromatosis or bilateral acoustic neuromas, vestibular schwannomas): from phenotype to gene].
Sabol Z; Kipke-Sabol L; Miklić P; Hajnsek-Propadalo S; Sabol F
Lijec Vjesn; 2006; 128(9-10):309-16. PubMed ID: 17128670
[TBL] [Abstract][Full Text] [Related]
35. Somatic Mosaicism of NF2 Gene Mutation with Constitutional NF1 Gene Mutation in Neurofibromatosis Type 2: a Case Report.
Yoo SJ; Hwang YS
Clin Lab; 2020 Nov; 66(11):. PubMed ID: 33180429
[TBL] [Abstract][Full Text] [Related]
36. Genetic aberrations in sporadic and neurofibromatosis 2 (NF2)-associated schwannomas studied by comparative genomic hybridization (CGH).
Antinheimo J; Sallinen SL; Sallinen P; Haapasalo H; Helin H; Horelli-Kuitunen N; Wessman M; Sainio M; Jääskeläinen J; Carpén O
Acta Neurochir (Wien); 2000; 142(10):1099-104; discussion 1104-5. PubMed ID: 11129530
[TBL] [Abstract][Full Text] [Related]
37. [Phenotype-genotype study in 154 French NF2 mutation carriers].
Demange L; De Moncuit C; Thomas G; Olschwang S
Rev Neurol (Paris); 2007 Nov; 163(11):1031-8. PubMed ID: 18033041
[TBL] [Abstract][Full Text] [Related]
38. Neuropathology and molecular genetics of neurofibromatosis 2 and related tumors.
Louis DN; Ramesh V; Gusella JF
Brain Pathol; 1995 Apr; 5(2):163-72. PubMed ID: 7670657
[TBL] [Abstract][Full Text] [Related]
39. Neurofibromatosis type 2 in an infant with multiple plexiform schwannomas as first symptom.
Miyakawa T; Kamada N; Kobayashi T; Hirano K; Fujii K; Sasahara Y; Nagai Y; Shinkai H
J Dermatol; 2007 Jan; 34(1):60-4. PubMed ID: 17204104
[TBL] [Abstract][Full Text] [Related]
40. Neurofibromatosis type 2: a new mechanism of tumor suppression.
Lutchman M; Rouleau GA
Trends Neurosci; 1996 Sep; 19(9):373-7. PubMed ID: 8873351
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
